Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4024)
All Articles published online
|
Oct 14, 2006 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hernandez-Alcoceba R, Sangro B, Prieto J. Gene therapy of liver cancer. World J Gastroenterol 2006; 12(38): 6085-6097 [PMID: 17036377 DOI: 10.3748/wjg.v12.i38.6085] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i38/6085.htm |
| Number | Citing Articles |
| 1 |
Weilin Wang, Pengfei Huang, Lufei Zhang, Jianfeng Wei, Qingsong Xie, Qiang Sun, Xiaohu Zhou, Haiyang Xie, Lin Zhou, Shusen Zheng. Antitumor efficacy of C‐X‐C motif chemokine ligand 14 in hepatocellular carcinoma in vitro and in vivo. Cancer Science 2013; 104(11): 1523 doi: 10.1111/cas.12279
|
| 2 |
Dhanwant Gomez, Dileep N. Lobo. Malignant liver tumours. Surgery (Oxford) 2011; 29(12): 632 doi: 10.1016/j.mpsur.2011.09.009
|
| 3 |
Cho Naing, Chee-Onn Leong, Htar Htar Aung, Chun-Wai Mai, Elaine Wan Ling Chan, Siang Tong Kew. Gene therapy for people with hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2020; doi: 10.1002/14651858.CD013731
|
| 4 |
Xuedan Huang, Akiko Kojima-Yuasa, Shenghui Xu, David Opare Kennedy, Tadayoshi Hasuma, Isao Matsui-Yuasa. Combination of Zizyphus jujuba and Green Tea Extracts Exerts Excellent Cytotoxic Activity in HepG2 Cells via Reducing the Expression of APRIL. The American Journal of Chinese Medicine 2009; 37(01): 169 doi: 10.1142/S0192415X09006758
|
| 5 |
Mariana G. Garcia, Juan Bayo, Marcela F. Bolontrade, Leonardo Sganga, Mariana Malvicini, Laura Alaniz, Jorge B. Aquino, Esteban Fiore, Manglio M. Rizzo, Andrés Rodriguez, Alicia Lorenti, Oscar Andriani, Osvaldo Podhajcer, Guillermo Mazzolini. Hepatocellular Carcinoma Cells and Their Fibrotic Microenvironment Modulate Bone Marrow-Derived Mesenchymal Stromal Cell Migration in Vitro and in Vivo. Molecular Pharmaceutics 2011; 8(5): 1538 doi: 10.1021/mp200137c
|
| 6 |
Marco Della Peruta, Adam Badar, Cecilia Rosales, Shilpa Chokshi, Azadeh Kia, Devhrut Nathwani, Eva Galante, Ran Yan, Erik Arstad, Andrew M. Davidoff, Roger Williams, Mark F. Lythgoe, Amit C. Nathwani. Preferential Targeting of Disseminated Liver Tumors Using a Recombinant Adeno-Associated Viral Vector. Human Gene Therapy 2015; 26(2): 94 doi: 10.1089/hum.2014.052
|
| 7 |
Zhuoyu Li, Ziming Han. Advancements of the CRISPR/Cas9 System in the Treatment of Liver
Cancer. Current Protein & Peptide Science 2024; 25(2): 154 doi: 10.2174/0113892037238265231006051215
|
| 8 |
Ana Carolina del Pozo, Patricia López. Management of Hepatocellular Carcinoma. Clinics in Liver Disease 2007; 11(2): 305 doi: 10.1016/j.cld.2007.04.007
|
| 9 |
Hiroaki Sawahara, Hidenori Shiraha, Daisuke Uchida, Hironari Kato, Ryo Kato, Atsushi Oyama, Teruya Nagahara, Masaya Iwamuro, Shigeru Horiguchi, Koichiro Tsutsumi, Mari Mandai, Tetsushige Mimura, Nozomu Wada, Yasuto Takeuchi, Kenji Kuwaki, Hideki Onishi, Shinichiro Nakamura, Masami Watanabe, Masakiyo Sakaguchi, Akinobu Takaki, Kazuhiro Nouso, Takahito Yagi, Yasutomo Nasu, Hiromi Kumon, Hiroyuki Okada. Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf‐3 expressing adenoviral vector for hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2017; 32(10): 1769 doi: 10.1111/jgh.13757
|
| 10 |
Kang-Jian Zhang, Jing Qian, Shi-Bing Wang, Yi Yang. Targeting Gene-Viro-Therapy with AFP driving Apoptin gene shows potent antitumor effect in hepatocarcinoma. Journal of Biomedical Science 2012; 19(1) doi: 10.1186/1423-0127-19-20
|
| 11 |
Bo-Rim Yi, Kyung-A. Hwang, Karen S. Aboody, Eui-Bae Jeung, Seung U. Kim, Kyung-Chul Choi. Selective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft models. Stem Cell Research 2014; 12(1): 36 doi: 10.1016/j.scr.2013.09.010
|
| 12 |
Xinmin Guo, Jianru Lin, Liwen Pan, Kun He, Zhihui Huang, Jialin Chen, Cuiyan Lin, Baohui Zeng, Sijia Luo, Mengdie Wang. Ultrasound-triggered release of miR-199a-3p from liposome nanobubbles for enhanced hepatocellular carcinoma treatment. Artificial Cells, Nanomedicine, and Biotechnology 2023; 51(1): 560 doi: 10.1080/21691401.2023.2268137
|
| 13 |
Yong Nan Jin, Hye Kyung Chung, Joo Hyun Kang, Yong Jin Lee, Kwang Il Kimm, Young Joo Kim, Seunghoo Kim, June-Key Chung. Radioiodine Gene Therapy of Hepatocellular Carcinoma Targeted Human Alpha Fetoprotein. Cancer Biotherapy and Radiopharmaceuticals 2008; 23(5): 551 doi: 10.1089/cbr.2008.0467
|
| 14 |
Seung Hoo Kim, Hye Kyung Chung, Joo Hyun Kang, Kwang Il Kim, Yong Hyun Jeon, Yong Nan Jin, Chae Ok Yun, June-Key Chung. Tumor-Targeted Radionuclide Imaging and Therapy Based on Human Sodium Iodide Symporter Gene Driven by a Modified Telomerase Reverse Transcriptase Promoter. Human Gene Therapy 2008; 19(9): 951 doi: 10.1089/hum.2008.030
|
| 15 |
BO-RIM YI, KELVIN J. CHOI, SEUNG U. KIM, KYUNG-CHUL CHOI. Therapeutic potential of stem cells expressing suicide genes that selectively target human breast cancer cells: Evidence that they exert tumoricidal effects via tumor tropism. International Journal of Oncology 2012; 41(3): 798 doi: 10.3892/ijo.2012.1523
|
| 16 |
Tetsuo Sugahara, Yzumi Yamashita, Masahito Shinomi, Yumiko Isobe, Banri Yamanoha, Hiroyoshi Iseki, Akihiko Takeda, Yasushi Okazaki, Kenji Kawai, Hiroshi Suemizu, Toshiwo Andoh. von Willebrand factor type D domain mutant of SVS‐1/SUSD2, vWDm, induces apoptosis in HeLa cells. Cancer Science 2007; 98(6): 909 doi: 10.1111/j.1349-7006.2007.00467.x
|
| 17 |
Travis Kidner, Menghua Dai, Prasad S. Adusumilli, Yuman Fong. Advances in Experimental and Translational Research in the Treatment of Hepatocellular Carcinoma. Surgical Oncology Clinics of North America 2008; 17(2): 377 doi: 10.1016/j.soc.2008.01.002
|
| 18 |
Xiujuan Zhang, Curlicia Turner, W T Godbey. Comparison of Caspase Genes for the Induction of Apoptosis Following Gene Delivery. Molecular Biotechnology 2009; 41(3): 236 doi: 10.1007/s12033-008-9133-9
|
| 19 |
Jae-Rim Heo, Kyung-A Hwang, Seung U. Kim, Kyung-Chul Choi. A Potential Therapy Using Engineered Stem Cells Prevented Malignant Melanoma in Cellular and Xenograft Mouse Models. Cancer Research and Treatment 2019; 51(2): 797 doi: 10.4143/crt.2018.364
|
| 20 |
Iván Lyra-González, Laura Esther Flores-Fong, Ignacio González-García, David Medina-Preciado, Juan Armendáriz-Borunda. Adenoviral gene therapy in hepatocellular carcinoma: a review. Hepatology International 2013; 7(1): 48 doi: 10.1007/s12072-012-9367-2
|
| 21 |
Weilin Wang, Pengfei Huang, Panyisha Wu, Rong Kong, Jiang Xu, Lufei Zhang, Qifan Yang, Qingsong Xie, Linshi Zhang, Xiaohu Zhou, Linghui Chen, Haiyang Xie, Lin Zhou, Shusen Zheng. BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis. Oncotarget 2015; 6(24): 20252 doi: 10.18632/oncotarget.3857
|
| 22 |
Cho Naing, Han Ni, Htar Htar Aung, Norah Htet Htet, Dimitrinka Nikolova. Gene therapy for people with hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2024; 2024(7) doi: 10.1002/14651858.CD013731.pub2
|
| 23 |
Akira Yamamoto, Takami Sato. Locoregional Treatment of Malignant Hepatic Tumors with Biologic Response Modifiers. Surgical Oncology Clinics of North America 2008; 17(4): 935 doi: 10.1016/j.soc.2008.04.001
|